Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3254540 | Best Practice & Research Clinical Gastroenterology | 2012 | 10 Pages |
Abstract
Diarrhoea is a common manifestation of Crohn's disease (CD). We advocate an evidence-based approach to treat the underlying disease and reduce symptoms. This article reviews disease grading systems, current concepts in medical therapy, and other treatments that may become available in the future. While some drug classes (e.g. salicylates, immunomodulators) have been studied for many decades, newer approaches including anti-TNF monoclonal antibodies (biologics), and gut selective agents are changing the paradigm we use to treat this debilitating condition.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
Charles Randall, John Vizuete, Gregg Wendorf, Balaji Ayyar, Gregory Constantine,